Property Summary

NCBI Gene PubMed Count 6
Grant Count 13
R01 Count 11
Funding $1,791,055.25
PubMed Score 78.35
PubTator Score 10.03

Knowledge Summary


No data available


  Differential Expression (3)

Disease log2 FC p
lung cancer 1.300 0.001
Breast cancer 1.500 0.000
ovarian cancer 1.500 0.000

Gene RIF (1)

18206972 ATXN7L3, USP22, & ENY2 are required cofactors for full transcriptional activity by nuclear receptors. The deubiquitinase activity of TFTC/STAGA HAT counteracts heterochromatin silencing & is a positive cofactor for in vivo nuclear receptor activation.

AA Sequence

ITPKGRALVPDSVKKELLQRIRTFLAQHASL                                            71 - 101

Text Mined References (12)

PMID Year Title
22814378 2012 N-terminal acetylome analyses and functional insights of the N-terminal acetyltransferase NatB.
22307388 2012 Functional and structural characterization of the mammalian TREX-2 complex that links transcription with nuclear messenger RNA export.
21746879 2011 The tightly controlled deubiquitination activity of the human SAGA complex differentially modifies distinct gene regulatory elements.
21269460 2011 Initial characterization of the human central proteome.
18206972 2008 A TFTC/STAGA module mediates histone H2A and H2B deubiquitination, coactivates nuclear receptors, and counteracts heterochromatin silencing.
16421571 2006 DNA sequence and analysis of human chromosome 8.
16344560 2006 Diversification of transcriptional modulation: large-scale identification and characterization of putative alternative promoters of human genes.
15489334 2004 The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).
14702039 2004 Complete sequencing and characterization of 21,243 full-length human cDNAs.
12477932 2002 Generation and initial analysis of more than 15,000 full-length human and mouse cDNA sequences.